The question "Pass program Praluent" likely refers to understanding the Praluent Access Program and its related components. The Praluent Access Program is designed to help eligible patients with commercial insurance obtain access to Praluent (alirocumab) [1].
What is the Praluent Access Program?
The Praluent Access Program offers eligible patients a free trial of Praluent for up to 12 months. It also provides a savings card that can reduce out-of-pocket costs for commercially insured patients for each prescription refill [1]. This program aims to mitigate the financial burden associated with the medication.
Who is Eligible for the Praluent Savings Card?
Eligibility for the Praluent Savings Card is for patients with commercial insurance who have a prescription for Praluent. There are specific terms and conditions that apply, and the program excludes patients who are uninsured, underinsured, or have government-funded insurance plans such as Medicare or Medicaid [1].
How Does the Praluent Free Trial Work?
The Praluent Free Trial provides eligible patients with a supply of Praluent at no cost for up to one year. This trial is intended to allow patients to experience the benefits of the medication without immediate financial commitment. Details on how to enroll and the specific duration and quantity of the free trial are available through the program [1].
What Costs Can Praluent Savings Card Cover?
For eligible commercially insured patients, the Praluent Savings Card can significantly lower out-of-pocket expenses for each prescription. The card offers savings of up to $200 off each 30-day supply, with a maximum annual savings of $2,400. This benefit is applied automatically when the card is presented at the pharmacy [1].
How Can I Enroll in the Praluent Access Program?
Enrollment in the Praluent Access Program typically involves obtaining a prescription from a healthcare provider and then activating the Praluent Savings Card. Information on activation and program details can be found on the official Praluent website or by contacting their patient support services [1].
What is Praluent Used For?
Praluent is a prescription medication used to lower LDL cholesterol, often referred to as "bad" cholesterol. It is indicated for adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD) on a maximally tolerated statin therapy, or for those who cannot tolerate statins [2].
How Does Praluent Work?
Praluent is a PCSK9 inhibitor. It works by blocking the PCSK9 protein, which increases the number of LDL receptors on the liver. These receptors then remove more LDL cholesterol from the blood [2].
What are the Side Effects of Praluent?
Common side effects of Praluent include cold symptoms (nasopharyngitis), flu-like symptoms, and injection site reactions [2]. More serious side effects are rare but can include allergic reactions. Patients should discuss potential side effects with their doctor.
When Does Praluent Patent Expiry?
Information regarding patent expiry dates for Praluent can be found on specialized pharmaceutical patent tracking websites, such as DrugPatentWatch.com [3]. These resources often provide detailed timelines for patent protection and potential market exclusivity.
Who are Praluent's Competitors?
Praluent, as a PCSK9 inhibitor, competes with other medications in the same class, such as Repatha (evolocumab). These drugs are used for similar indications of lowering LDL cholesterol [4].
Sources:
1. https://www.praluent.com/savings-and-access
2. https://www.praluent.com/
3. https://drugpatentwatch.com/
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588528/